TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 4 | 2 | 4 | -14 | -12 | -27 | -7 |
| P | %wins | 100 | 67 | 67 | 50 | 0 | 0 | 47 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/4/17 16:40 | 3/31/17 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Forrest Kevin | CA | O | Chief Sc | P.d | 97 | 7.75 | 1 | 13 | 21 | 72 | D | -42 | -35 | -29 | 3 | 6 | -1 | -1 | 6 | 0 | 5 | ||||
5/23/16 16:34 | 5/20/16 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Forrest Kevin | CA | O | COO,CFO | P | 50 | 11.53 | 1 | 4 | 8 | 58 | D | -30 | -17 | 3 | -16 | -18 | -7 | -2 | 2 | -1 | -11 | 5 | -2 | ||
11/23/15 19:18 | 11/23/15 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Forrest Kevin | CA | O | COO,CFO | P | 101 | 14.23 | 0 | 7 | 16 | 52 | D | -15 | -1 | 2 | -5 | -6 | 6 | 3 | 6 | 17 | -32 | -22 | -27 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |